Related Experiment Video

Updated: Jan 28, 2026

Isolation of Rat Adipose Tissue Mesenchymal Stem Cells for Differentiation into Insulin-producing Cells
08:09

Isolation of Rat Adipose Tissue Mesenchymal Stem Cells for Differentiation into Insulin-producing Cells

Published on: August 29, 2022

8.5K

Small molecules and extrinsic factors promoting differentiation of stem cells into insulin-producing cells

Gui Pan1, Jianping Liu1

  • 1Department of Endocrinology, the Second Affiliated Hospital of Nanchang University, No. 1, Minde Road, Jiangxi Province, 330006 Nanchang, China.

Annales D'Endocrinologie
|March 6, 2019
PubMed

Insights

Type-2 diabetes is a growing health concern. Research explores stem cell therapies, including induced pluripotent stem cells (iPSCs), to generate insulin-producing cells (IPCs) for potential diabetes treatment.

Area of Science:

  • Biomedical Science
  • Regenerative Medicine
  • Endocrinology

Background:

  • Type-2 diabetes mellitus (T2DM) presents a significant global health challenge, marked by rising prevalence and severe morbidity/mortality risks.
  • Current T2DM treatments include oral agents and insulin therapy, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To review the development of stem cell-based therapies for T2DM, focusing on generating insulin-producing cells (IPCs).
  • To highlight the critical factors influencing the success of induced pluripotent stem cell (iPSC) differentiation for therapeutic applications.

Main Methods:

  • Review of current literature on stem cell sources for T2DM therapy.
  • Analysis of protocols for inducing stem cell differentiation into IPCs.
  • Examination of factors affecting iPSC induction, including cell quality and extrinsic molecular signals.

Main Results:

  • Various stem cell types (ESCs, MSCs, iPSCs, adult stem cells) show potential for generating IPCs.
  • iPSC induction efficacy is contingent on stem cell quantity/quality and optimized differentiation protocols.
  • Small molecules and specific environmental factors are crucial for successful iPSC differentiation.

Conclusions:

  • Stem cell-based therapies offer a promising avenue for T2DM treatment.
  • Further research and validation of protocols are essential for the clinical translation of iPSC-derived IPCs.
  • Rigorous experimental rationale is required for validating novel cell therapies for diabetes.
Keywords:
Cellules pluripotentesCellules souchesCellules sécrétant de l’insulineExtrinsic factorsFacteurs extrinsèquesInsulin-producing cellsPluripotent stem cellsReprogrammationReprogrammingStem cells

More Related Videos

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters08:41

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Published on: June 23, 2023

4.3K
Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation06:55

Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation

Published on: July 17, 2019

15.4K

Related Concept Videos

Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.3K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.0K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.8K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.4K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.7K